Log in

NASDAQ:AGLEAeglea Bio Therapeutics SEC Filings & 10K Form

$5.44
+0.23 (+4.41 %)
(As of 04/10/2020 03:02 AM ET)
Add
Compare
Today's Range
$5.06
Now: $5.44
$5.69
50-Day Range
$3.51
MA: $5.61
$8.22
52-Week Range
$3.50
Now: $5.44
$9.10
Volume118,361 shs
Average Volume65,562 shs
Market Capitalization$158.22 million
P/E RatioN/A
Dividend YieldN/A
Beta1.38

SEC Filings

Aeglea Bio Therapeutics (NASDAQ:AGLE) SEC Filings

DateFilerForm TypeView
04/08/2020
6:30 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2020
7:28 AM
Aeglea Bio Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/24/2020
6:34 AM
Aeglea Bio Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/24/2020
6:30 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2020
4:15 PM
Aeglea Bio Therapeutics (Issuer)
York Charles N II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
4:14 PM
Aeglea Bio Therapeutics (Issuer)
Sloan Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
4:14 PM
Aeglea Bio Therapeutics (Issuer)
Rao Madduri Ravin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
4:13 PM
Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
4:12 PM
Aeglea Bio Therapeutics (Issuer)
Hanley Jr. Michael Conick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
11:00 AM
Aeglea Bio Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/13/2020
3:17 PM
Aeglea Bio Therapeutics (Subject)
Lilly Ventures Fund I LLC (Filed by)
Form SC 13G/A
02/12/2020
3:12 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Aeglea Bio Therapeutics (Subject)
Form SC 13G/A
02/06/2020
1:01 PM
Aeglea Bio Therapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
02/03/2020
1:43 PM
Aeglea Bio Therapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
Form SC 13G/A
01/30/2020
3:12 PM
Aeglea Bio Therapeutics (Subject)
Novartis Bioventures Ltd (Filed by)
Form SC 13G/A
01/13/2020
4:20 PM
Aeglea Bio Therapeutics (Filer)
Form 8-K/A
01/13/2020
6:01 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2019
7:00 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
7:34 AM
Aeglea Bio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
7:30 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
4:21 PM
Aeglea Bio Therapeutics (Issuer)
Rao Madduri Ravin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
4:20 PM
Aeglea Bio Therapeutics (Issuer)
Rao Madduri Ravin (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/23/2019
3:09 PM
Aeglea Bio Therapeutics (Issuer)
Hanley Jr. Michael Conick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2019
3:08 PM
Aeglea Bio Therapeutics (Issuer)
Hanley Jr. Michael Conick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/07/2019
3:09 PM
Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
6:30 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2019
5:03 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
7:03 AM
Aeglea Bio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
7:00 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
4:22 PM
Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:52 PM
Aeglea Bio Therapeutics (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:51 PM
Aeglea Bio Therapeutics (Issuer)
Shanafelt Armen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:50 PM
Aeglea Bio Therapeutics (Issuer)
Mahatme Sandesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:49 PM
Aeglea Bio Therapeutics (Issuer)
Magovcevic Ivana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:49 PM
Aeglea Bio Therapeutics (Issuer)
Cox Russell J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:48 PM
Aeglea Bio Therapeutics (Issuer)
Bruhn Suzanne Louise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:05 PM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2019
3:55 PM
Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
4:04 PM
Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2019
6:51 AM
Aeglea Bio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
6:45 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
4:05 PM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2019
7:00 AM
Aeglea Bio Therapeutics (Filer)
Form DEF 14A
04/08/2019
5:05 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2019
3:41 PM
Aeglea Bio Therapeutics (Issuer)
Sloan Leslie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2019
3:41 PM
Aeglea Bio Therapeutics (Issuer)
Sloan Leslie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/08/2019
3:30 PM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2019
4:16 PM
Aeglea Bio Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2019
3:05 PM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
5:08 AM
Aeglea Bio Therapeutics (Subject)
Nantahala Capital Management, LLC (Filed by)
Form SC 13G/A
02/13/2019
11:15 PM
Aeglea Bio Therapeutics (Filer)
Form EFFECT
02/13/2019
3:29 PM
Aeglea Bio Therapeutics (Subject)
BAKER BROS. ADVISORS LP (Filed by)
Form SC 13G/A
02/11/2019
4:18 PM
Aeglea Bio Therapeutics (Filer)
Form S-3/A
02/08/2019
3:15 PM
Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2019
8:40 PM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2019
8:37 PM
Aeglea Bio Therapeutics (Filer)
Form 424B5
02/05/2019
3:49 PM
Aeglea Bio Therapeutics (Filer)
Form 424B5
01/31/2019
3:37 PM
Aeglea Bio Therapeutics (Subject)
PRUDENTIAL FINANCIAL INC (Filed by)
PRUDENTIAL FINANCIAL INC (Filed by)
Form SC 13G/A
01/31/2019
10:20 AM
Aeglea Bio Therapeutics (Subject)
JENNISON ASSOCIATES LLC (Filed by)
Form SC 13G/A
12/21/2018
3:01 PM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2018
4:05 PM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2018
3:05 PM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
4:40 PM
Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2018
7:00 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
7:04 AM
Aeglea Bio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
7:00 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2018
7:00 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2018
5:59 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2018
9:26 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Aeglea Bio Therapeutics (Subject)
Form SC 13G
10/10/2018
8:00 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2018
4:11 PM
Aeglea Bio Therapeutics (Issuer)
Schuchart Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2018
4:00 PM
Aeglea Bio Therapeutics (Filer)
Form DEF 14A
09/04/2018
6:00 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2018
3:24 PM
Aeglea Bio Therapeutics (Issuer)
Schuchart Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
3:40 PM
Aeglea Bio Therapeutics (Issuer)
GEORGIOU GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
7:06 AM
Aeglea Bio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2018
7:00 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2018
3:30 PM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2018
4:26 PM
Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2018
3:27 PM
Aeglea Bio Therapeutics (Issuer)
LAWLIS V BRYAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2018
3:26 PM
Aeglea Bio Therapeutics (Issuer)
LAWLIS V BRYAN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/16/2018
8:04 AM
Aeglea Bio Therapeutics (Issuer)
Quinn Anthony G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2018
7:00 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2018
5:47 PM
Aeglea Bio Therapeutics (Issuer)
Shanafelt Armen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
5:45 PM
Aeglea Bio Therapeutics (Issuer)
Mahatme Sandesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
5:44 PM
Aeglea Bio Therapeutics (Issuer)
GEORGIOU GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
5:43 PM
Aeglea Bio Therapeutics (Issuer)
Cox Russell J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2018
5:42 PM
Aeglea Bio Therapeutics (Issuer)
Bruhn Suzanne Louise (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2018
5:20 AM
Aeglea Bio Therapeutics (Subject)
Novartis Bioventures Ltd (Filed by)
Form SC 13G/A
05/14/2018
3:01 PM
Aeglea Bio Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
3:28 PM
Aeglea Bio Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
3:01 PM
Aeglea Bio Therapeutics (Issuer)
NOVARTIS AG (Reporting)
Novartis Bioventures Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2018
7:06 AM
Aeglea Bio Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2018
7:00 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2018
3:06 PM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2018
3:02 PM
Aeglea Bio Therapeutics (Filer)
Form 424B5
04/17/2018
3:07 PM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2018
3:03 PM
Aeglea Bio Therapeutics (Filer)
Form 424B5
04/16/2018
6:03 AM
Aeglea Bio Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2018
6:00 AM
Aeglea Bio Therapeutics (Filer)
Form DEF 14A
This page was last updated on 4/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel